A Comparative Study of Sibling Oocytes: ICSI vs. the IMSI Sperm Selection Method

NCT ID: NCT03240276

Last Updated: 2017-08-07

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

50 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-09-30

Study Completion Date

2020-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this research is to compare sibling oocytes using two sperm selection methods for choosing the best quality spermatozoa before they are injected into oocytes and the influence of each of these methods on embryo quality and IVF outcome.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Infertility

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

ICSI Procedure

The ICSI procedure is the standard procedure of selection and injection of sperm into the oocyte

Group Type ACTIVE_COMPARATOR

Standard ICSI procedure for sperm injection into oocyte

Intervention Type OTHER

The ICSI procedure is the standard procedure of selection and injection of sperm into oocytes

IMSI Procedure

The IMSI procedure is the injection of normal ultramorphological spermatozoa that have been selected using an inverted microscope with magnification of 6300x (MSOME)

Group Type ACTIVE_COMPARATOR

MSOME

Intervention Type DEVICE

Selection of ultramorphologically normal spermatozoa using an inverted microscope with 6300x magnification

IMSI Procedure

Intervention Type OTHER

Injection of sperm that has been selected by the MSOME method into oocytes

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Standard ICSI procedure for sperm injection into oocyte

The ICSI procedure is the standard procedure of selection and injection of sperm into oocytes

Intervention Type OTHER

MSOME

Selection of ultramorphologically normal spermatozoa using an inverted microscope with 6300x magnification

Intervention Type DEVICE

IMSI Procedure

Injection of sperm that has been selected by the MSOME method into oocytes

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Motile Sperm Organelle Morphology Examination

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Males aged 18-60
* Females aged 18-35
* Males defined as Moderate OTA or Isolated Teratozoospermia with less than 4% morphologically normal spermatozoa
* Patients with 0.5- 7% normal sperm according to MSOME analysis
* Females with normal FSH and AMH values
* Females who have retrieved at least 6 oocytes in previous cycles
* Couples who have had at least 2 failed IVF-ICSI cycles

Exclusion Criteria

* Couples who have been exposed to heavy smoking, drugs and chronic diseases
* Males who have undergone testicular surgery (TESE) or defined as severe OTA
* Females with egg factor infertility
Minimum Eligible Age

18 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hillel Yaffe Medical Center

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Einat Shalom Paz, MD

Role: PRINCIPAL_INVESTIGATOR

Hillel Yaffe Medical Center

Medeia Michaeli, PhD

Role: STUDY_DIRECTOR

Hillel Yaffe Medical Center

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hillel Yaffe Medical Center

Hadera, , Israel

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Israel

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Medeia Michaeli, PhD

Role: CONTACT

972-50-6246885

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Medeia Michaeli, PhD

Role: primary

972-50-6246885

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

HYMC-0070-17

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Use of IMSI in Poor Responders to IVF
NCT02358733 TERMINATED NA